Skip to content

Author

Richard Andrews

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Cardiometabolic benefits of glucagon-like peptide-1 receptor agonists and dual agonists: from obesity and diabetes to heart failure with preserved ejection fraction.

INTRODUCTION Heart failure with preserved ejection fraction (HFpEF) accounts for over half of all heart failure hospitalisations and is increasing in prevalence, largely driven by obesity and Type 2 Diabetes Mellitus (T2DM). Glucagon-like-peptide receptor agonists (GLP-1 RAs) and the dual GLP-1/GIP agonist, tirzepatide...

R. Chotalia, Owais Ghias, Muhammad Usman Shah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.